In preclinical studies, the team targeted EZH2's alternative activities to assess potential treatment solutions. They found that inhibiting either protein synthesis or the TGF-β pathway ...

The critical role of EZH2, an essential epigenetic regulator, in cancer progression and treatment is underscored in this new review article published in Genes & Diseases. The study highlights the ...

Inhibitory role of bone marrow mesenchymal stem cells-derived exosome in non-small-cell lung cancer: microRNA-30b-5p, EZH2 and PI3K/AKT pathway.